Fairmount Healthcare Fund L.P. is Director & 10% Owner at Viridian Therapeutics, Inc.\DE (VRDN). They have made 1 open-market trade across 1 company since 2021, most recently 2021-09-21.
CIK 0001686157
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $10.0M since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VRDN | 938,233 | $17.9M |
Shares reported on the most recent Form 4, priced at the 2021-09-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VRDN | BUY | 2021-09-21 | 2021-09-23 | $11.00 | $10.0M | +22.9% | +23.0% | +46.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.